相似文献
1
Cell culture-derived flu vaccine: Present and future.
Hum Vaccin Immunother. 2018;14(8):1874-1882. doi: 10.1080/21645515.2018.1460297. Epub 2018 Jun 28.
2
Inactivated quadrivalent split-virus seasonal influenza vaccine (Fluarix® quadrivalent): a review of its use in the prevention of disease caused by influenza A and B.
Drugs. 2013 Sep;73(14):1587-94. doi: 10.1007/s40265-013-0114-3.
3
Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults.
BMC Infect Dis. 2013 May 20;13:224. doi: 10.1186/1471-2334-13-224.
4
Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects.
Hum Vaccin Immunother. 2017 Jul 3;13(7):1653-1660. doi: 10.1080/21645515.2017.1297351. Epub 2017 Apr 13.
5
Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018.
J Infect Dis. 2019 Sep 13;220(8):1255-1264. doi: 10.1093/infdis/jiy716.
6
Quadrivalent cell culture influenza virus vaccine. Comparison to egg-derived vaccine.
Hum Vaccin Immunother. 2020 Aug 2;16(8):1746-1752. doi: 10.1080/21645515.2019.1701912. Epub 2020 Apr 7.
7
The rationale for quadrivalent influenza vaccines.
Hum Vaccin Immunother. 2012 Jan;8(1):81-8. doi: 10.4161/hv.8.1.17623. Epub 2012 Jan 1.
8
Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
PLoS One. 2018 Dec 3;13(12):e0208028. doi: 10.1371/journal.pone.0208028. eCollection 2018.
9
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.
MMWR Recomm Rep. 2022 Aug 26;71(1):1-28. doi: 10.15585/mmwr.rr7101a1.
10
Cell culture-based influenza vaccines: A necessary and indispensable investment for the future.
Hum Vaccin Immunother. 2015;11(5):1223-34. doi: 10.1080/21645515.2015.1016666.
引用本文的文献
1
Insect-specific virus platforms for arbovirus vaccine development.
Front Immunol. 2025 Mar 14;16:1521104. doi: 10.3389/fimmu.2025.1521104. eCollection 2025.
2
Mass Spectrometry-Based Applications of Spheroids in Cancer Biology.
Annu Rev Anal Chem (Palo Alto Calif). 2025 May;18(1):173-191. doi: 10.1146/annurev-anchem-061424-090547. Epub 2025 Jan 14.
3
Protein Expression Platforms and the Challenges of Viral Antigen Production.
Vaccines (Basel). 2024 Nov 28;12(12):1344. doi: 10.3390/vaccines12121344.
4
Preventing Influenza Virus Infection and Severe Influenza Among Pregnant People and Infants.
J Womens Health (Larchmt). 2024 Dec;33(12):1591-1598. doi: 10.1089/jwh.2024.0893. Epub 2024 Nov 4.
5
Production, Passaging Stability, and Histological Analysis of Madin-Darby Canine Kidney Cells Cultured in a Low-Serum Medium.
Vaccines (Basel). 2024 Aug 30;12(9):991. doi: 10.3390/vaccines12090991.
6
MDCK-Adaptive Mutation of A169S Changes Glycosylation Pattern of Hemagglutinin and Enhances MDCK-Based H7N9 Vaccine Virus Production without Loss of Antigenicity and Immunogenicity.
Vaccines (Basel). 2024 Mar 11;12(3):291. doi: 10.3390/vaccines12030291.
7
Adjuvanted nanoliposomes displaying six hemagglutinins and neuraminidases as an influenza virus vaccine.
Cell Rep Med. 2024 Mar 19;5(3):101433. doi: 10.1016/j.xcrm.2024.101433. Epub 2024 Feb 23.
8
Synthetic Cell Lines for Inducible Packaging of Influenza A Virus.
ACS Synth Biol. 2024 Feb 16;13(2):546-557. doi: 10.1021/acssynbio.3c00526. Epub 2024 Jan 23.
9
The Screening and Mechanism of Influenza-Virus Sensitive MDCK Cell Lines for Influenza Vaccine Production.
Diseases. 2024 Jan 10;12(1):20. doi: 10.3390/diseases12010020.
10
Targeting neuraminidase: the next frontier for broadly protective influenza vaccines.
Trends Immunol. 2024 Jan;45(1):11-19. doi: 10.1016/j.it.2023.11.001. Epub 2023 Dec 15.
本文引用的文献
1
Respiratory Influenza A Virus Infection Triggers Local and Systemic Natural Killer Cell Activation Toll-Like Receptor 7.
Front Immunol. 2018 Feb 13;9:245. doi: 10.3389/fimmu.2018.00245. eCollection 2018.
2
Influenza A viruses alter the stability and antiviral contribution of host E3-ubiquitin ligase Mdm2 during the time-course of infection.
Sci Rep. 2018 Feb 27;8(1):3746. doi: 10.1038/s41598-018-22139-6.
3
Egg-Independent Influenza Vaccines and Vaccine Candidates.
Vaccines (Basel). 2017 Jul 18;5(3):18. doi: 10.3390/vaccines5030018.
4
A systematic review of the health economic consequences of quadrivalent influenza vaccination.
Expert Rev Pharmacoecon Outcomes Res. 2017 Jun;17(3):249-265. doi: 10.1080/14737167.2017.1343145. Epub 2017 Jun 28.
5
A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.
Hum Vaccin Immunother. 2017 Jul 3;13(7):1640-1652. doi: 10.1080/21645515.2017.1313375. Epub 2017 May 22.
6
Safety and tolerability of cell culture-derived and egg-derived trivalent influenza vaccines in 3 to <18-year-old children and adolescents at risk of influenza-related complications.
Int J Infect Dis. 2016 Aug;49:171-8. doi: 10.1016/j.ijid.2016.06.018. Epub 2016 Jun 23.
7
Safety and tolerability of a cell culture derived trivalent subunit inactivated influenza vaccine administered to healthy children and adolescents: A Phase III, randomized, multicenter, observer-blind study.
Vaccine. 2016 Jan 4;34(2):230-236. doi: 10.1016/j.vaccine.2015.11.040. Epub 2015 Nov 29.
8
Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009-13.
Lancet Respir Med. 2015 Sep;3(9):709-718. doi: 10.1016/S2213-2600(15)00278-7. Epub 2015 Aug 21.
9
Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study.
Influenza Other Respir Viruses. 2015 Aug;9 Suppl 1(Suppl 1):3-12. doi: 10.1111/irv.12319.
10
Cell culture-based influenza vaccines: A necessary and indispensable investment for the future.
Hum Vaccin Immunother. 2015;11(5):1223-34. doi: 10.1080/21645515.2015.1016666.
Zotero 插件